(EL4A) Deka DAX - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: DE000ETFL011 • Germany Equity
EL4A: German, Stocks, Bonds, Equities
The Deka DAX UCITS ETF (Ticker: EL4A), listed on XETRA, is a UCITS-compliant exchange-traded fund designed to track the performance of the Morningstar Germany TME NR EUR index. This index focuses on large-cap German equities, providing exposure to some of the countrys most established companies, such as SAP, Siemens, and others that dominate the German economy. With an AUM of 1.29 billion EUR, this ETF is a substantial player in the European ETF market, offering investors a liquid and cost-effective way to gain exposure to German equities.
The ETFs expense ratio is 0.15%, which is relatively low for a European equity ETF, making it an attractive option for cost-conscious investors. The fund is denominated in euros and trades on XETRA, making it accessible to both European and international investors looking for exposure to the German market. The Morningstar Germany TME NR EUR index is designed to represent the performance of large-cap German companies, ensuring that the ETF is well-diversified across key sectors such as industrials, consumer goods, and technology.
One of the key advantages of this ETF is its focus on large-cap companies, which tend to be more stable and less volatile than smaller-cap firms. However, this also means that the fund is less exposed to the growth potential of smaller German companies. The ETFs performance is closely tied to the overall health of the German economy, which has historically been resilient but is also sensitive to global trade dynamics and geopolitical factors.
For investors and fund managers, the Deka DAX UCITS ETF offers a straightforward way to gain exposure to the German equity market without the need for direct stock picking. The funds UCITS compliance ensures that it meets strict European regulatory standards, providing a level of investor protection and transparency. Additionally, the ETFs large AUM and established track record make it a reliable choice for those looking to allocate to German equities as part of a diversified portfolio.
However, its important to note that the funds focus on large-cap companies means it may not capture the entire breadth of the German equity market, including mid- and small-cap firms. Investors seeking broader exposure to the German market may
Additional Sources for EL4A ETF
EL4A ETF Overview
Market Cap in USD | 1,402m |
Category | Germany Equity |
IPO / Inception | 2008-03-14 |
EL4A ETF Ratings
Growth 5y | 86.2% |
Fundamental | - |
Dividend | 9.69% |
Rel. Strength Industry | 0.03 |
Analysts | - |
Fair Price Momentum | 212.60 EUR |
Fair Price DCF | - |
EL4A Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 32.3% |
EL4A Growth Ratios
Growth Correlation 3m | 92% |
Growth Correlation 12m | 87.9% |
Growth Correlation 5y | 79.1% |
CAGR 5y | 19.68% |
CAGR/Max DD 5y | 0.74 |
Sharpe Ratio 12m | 2.14 |
Alpha | 18.71 |
Beta | 0.54 |
Volatility | 26.06% |
Current Volume | 4.6k |
Average Volume 20d | 9.5k |
As of March 14, 2025, the stock is trading at EUR 198.88 with a total of 4,578 shares traded.
Over the past week, the price has changed by -3.41%, over one month by -0.29%, over three months by +10.45% and over the past year by +24.86%.
Yes. Based on ValueRay Analyses, Deka DAX (XETRA:EL4A) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 86.15 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EL4A as of March 2025 is 212.60. This means that EL4A is currently overvalued and has a potential downside of 6.9%.
Deka DAX has no consensus analysts rating.
According to ValueRays Forecast Model, EL4A Deka DAX will be worth about 234.4 in March 2026. The stock is currently trading at 198.88. This means that the stock has a potential upside of +17.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 234.4 | 17.9% |